Protecting Genetic Data - A Primer for Employers
By Jeremy Gruber,
Council for Responsible Genetics Blog
| 07. 02. 2014
Untitled Document
As genetic testing and genetic information become increasingly available, it is critical that employers have a full understanding of current genetic privacy and nondiscrimination protections, to ensure their workplaces are in full compliance with federal and state laws. For example, the U.S. Genetic Information Nondiscrimination Act (GINA) took effect on November 21, 2009, yet many employers still are unfamiliar with its provisions. Many are even less familiar with applicable state genetic privacy laws, despite enhanced enforcement of both federal and state laws.
Federal law:
GINA and employment
Prohibitions
One section of GINA, called Title II, applies equally to employers, employment agencies, labor organizations, and joint labor-management committees that control job training. This section of the law makes it an unlawful employment practice for an employer to “fail or refuse to hire ... discharge ... or otherwise to discriminate against any employee with respect to the compensation, terms, conditions, or privileges of employment” because of an employee’s genetic information. Generally, a person’s genetic information is defined as information obtained from the individual’s genetic tests, those of the individual’s family...
Related Articles
By Carly Mallenbaum, Axios [cites Emily Galpern] | 03.29.2026
More Americans are turning to surrogacy to build their families, as the practice becomes more common and more publicly discussed.
Why it matters: As surrogacy becomes more visible and accessible, ethical, legal and cultural tensions become harder to ignore...
By Carly Mallenbaum, Axios [cites Surrogacy360] | 03.29.2026
Without a federal law, surrogacy in the U.S. is governed by a patchwork of state regulations/
Why it matters: Confusing, varied local rules can determine everything from whether agreements are legally binding to who is recognized as a parent at...
Cathy Tie seems to be good at starting businesses but not so dedicated to maintaining them. CGS, like many others, first heard of her thanks to Caiwei Chen and Antonio Regalado in MIT Technology Review, May 2025, as the partner (perhaps bride) of the notorious Chinese scientist He Jiankui, described in the headline as “China’s Frankenstein.” He prefers “Chinese Darwin.” She ran his Twitter account for a while, contributing such gems as:
Get in luddite, we’re going gene editing...
By Laura DeFrancesco, Nature Biotechnology | 03.17.2026
The first gene editors designed to fix genetic lesions in mutation-agnostic ways are poised to enter the clinic. Tessera Therapeutics and Alltrna, two Flagship Pioneering-funded companies, are gearing up to test novel genetic medicines in humans. Tessera received regulatory clearance...